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Abstract
The community blood supply is a limited resource with a relatively short shelf-life. To ensure an
adequate supply, a balance must be maintained between the numbers of donors providing blood
and blood products required by hospitals to meet patient needs. Any change in the number of
blood donors or in the volume of blood required by hospitals can create a blood shortage.
During times of disaster, a blood shortage may be inevitable. Additional strategies must be in
place to ensure availability of blood for essential transfusions across the community.
Cryopreservation of red blood cells to build and maintain a blood product reserve has been
considered a possible strategy for many years. However, red blood cell products prepared by the
traditional process expired 24 hours after thawing, allowing only that time for successful
transfusion. This was not practical from an emergency preparedness perspective. Haemonetics
Corporation has developed an Automated Cell Processor (ACP-215) that both freezes and thaws
a red blood cell product in a system that allows for long-term storage of the blood product and
extends the shelf-life of this thawed product to 14 days. This research conducted a cost-benefit
analysis of the ACP-215 to determine the feasibility of implementation of this instrument by the
Dayton Community Blood Center to establish a frozen red blood cell reserve and improve its
emergency preparedness efforts.

Keywords: ACP-215, red blood cell cryopreservation, strategic blood supply, transfusion
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The Feasibility of Implementing the ACP-215 at the Dayton Community Blood Center: A
Cost-Benefit Analysis
Transfusion medicine is a medical specialty that focuses on the transfusion of blood and
blood components for patients who are in need of this medical procedure for various reasons.
The majority of these blood products are acquired by hospitals from local community blood
centers (Erickson et al., 2008). The Dayton Community Blood Center (DCBC), located in
Dayton, Ohio, is the single provider of transfusion blood products for 25 hospitals in the Greater
Dayton Area. During normal routine operations, the DCBC cost-effectively manages its own
blood component inventory using strategies that maximize efficiency and minimize wastage
(DCBC Inventory Senior Staff, 1 March 2013). However, what if blood supplies were suddenly
insufficient or depleted during an ongoing emergency or disaster situation, creating a critical
shortage of blood products?
Disaster or emergency situations refer to any crisis that temporarily restricts or eliminates
the ability of a blood transfusion service to maintain its supply of blood products or to meet the
sudden increase in demand for these blood products as a result of the particular crisis. Specific
disaster or emergency scenarios include destructive acts of terrorism, mass casualties, major
storms, floods, earthquakes, epidemic infectious disease outbreaks, or seasonal shortages limiting
the number of available donors. These situations can create a challenging impact on the supply
of blood donors, blood service staff, blood center volunteers, and blood products, as well as on
patients, hospitals and the general public (Kuruppu, 2010; Erickson et al., 2008; Ramsey, 2008)
The solution to this dilemma is the establishment of a reserve strategic blood supply so
that the demand for blood products is always met under any circumstances, without the need to
spend a large amount of money to acquire blood products from outside sources. This is done by
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having a reserve of frozen red blood cells, which can then be stored for 10 years, with at least the
same, if not better, efficacy and safety as fresh liquid red blood cells (DCBC Transfusion
Services Senior Staff, 12 February 2013; Erickson et al., 2008; Ramsey, 2008).
However, red blood cell (RBC) products prepared by the traditional process expired 24
hours after thawing, allowing only that time for successful transfusion. This is not ideal from an
emergency preparedness perspective. Therefore, in 1998, the Haemonetics Corporation
developed an Automated Cell Processor named the ACP-215 that both freezes and thaws
products in a closed system that allows for long-term storage and extends the shelf-life of a
thawed product to 14 days (DCBC Transfusion Services Senior Staff, 12 February 2013;
Chaudhari, 2009; Erickson et al., 2008; Ramsey, 2008; Bandarenko et al., 2007; Valeri & Ragno,
2006). A closed system uses sterile techniques during the freezing and thawing processes to
lower potential bacterial contamination of the final RBC product and extends the post-thaw
shelf-life of this product (DCBC Transfusion Technician, 7 March 2013; Haemonetics Sales
Representative, 25 February 2013).
Currently, the United States military and large community hospitals are the primary
consumers of the ACP-215 as blood transfusions are highly demanded in these locations. The
ACP-215 is used by only 2 to 3 small local community blood centers with little published data
discussing the benefits or potential cost-savings with implementation of this instrument by these
community blood collection centers (Haemonetics Sales Representative, 25 February 2013). As
stated previously, the DCBC is the sole provider of transfusion blood products for 25 hospitals in
the Greater Dayton Area (DCBC Inventory Senior Staff, 1 March 2013). The establishment of a
strategic frozen RBC reserve is a potential solution to cost-effectively meeting the community’s
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blood product needs at all times and improving the Greater Dayton Area’s emergency
preparedness efforts.
This research, designed as a case study, performed a cost-benefit analysis on the ACP215 instrument. It determined the feasibility of the not-for-profit DCBC to employ this medical
device in its daily operations, based on the operational advantages and disadvantages and the
overall annual costs and savings afforded to the DCBC with implementation of the ACP-215.
The primary investigator hypothesized that ACP-215 implementation would benefit the DCBC
from a cost-savings and emergency preparedness perspective.
Literature Review
Blood Transfusion
Blood transfusion is one of the top 5 hospital procedures and expenses. Every year,
approximately 4.5 million Americans require a blood transfusion, as someone needs blood every
two seconds. These transfusion requirements use 43,000 pints of donated blood every day in the
United States and Canada (DCBC Transfusion Services Senior Staff, 12 February 2013;
America’s Blood Centers [ABC], 2013). There are four main red blood cell groups: A, B, AB
and O. Each group can be positive or negative for the Rh factor. AB is the universal recipient
and O negative is the universal donor of red blood cells. The demand is greatest for O negative
blood because it is commonly transfused in trauma cases and other emergency cases when the
blood type of the recipient is not immediately known (ABC, 2013; James, Hillyer, & Shaz,
2012).
Blood Product Supply and Demand
The transfusion process demonstrates the classic supply and demand model, in which the
demand for blood products from hospitals, transfusion services, and the public significantly
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influences the supply of blood products, or needed blood donations. A lack of blood occurs
when the supply, or number of blood donations, is unable to meet the demand, or transfusion
needs, of patients and hospitals (Sacchini et al., 2013).
The demand for blood products is rising, as blood transfusions continue to increase
approximately five to seven percent (5-7%) per year without a similar boost in donations (James
et al., 2012; Pittoco & Sexton, 2012). The aging population, the increase in medical technology
such as organ transplantations and cancer chemotherapy treatments, and the rise of other surgical
procedures contribute to the rising demand. This phenomenon mandates a mutual growth in
blood collections from the suppliers by approximately seven percent (7%) to meet this overall
patient demand. Unfortunately, increased donor rejections due to stricter donor eligibility
regulations, donated units failing strict infectious disease transmission testing criteria, and tight
donor recruiting budget restraints will make it difficult to provide an adequate supply of blood
products (Erickson et al., 2008; Zou, Musavi, Notari, & Fang, 2008; McCarthy, 2007; Pitocco &
Sexton, 2005).
The three major blood product suppliers in the United States include a large network of
interconnected, community-based blood centers known as America’s Blood Centers (ABC), the
American Red Cross (ARC), and various hospitals that have their own blood banks. The ABC
and ARC each contribute about 45 percent to the nation’s blood supply. The US hospitals, as
well as other independent blood centers and the Department of Defense, contribute
approximately 10 percent to the national supply. Ideally, suppliers prefer to maintain a three-day
inventory supply at any given time (Erickson et al., 2008; Ramsey, 2008; United States General
Accounting Office [USGAO], 2002).
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Current mathematical models state that approximately 120 million people in the United
States, or 40 percent of the population, are eligible to donate one pint of blood every two months.
However, of this eligible population, only five percent (5%) donate blood at least once each year
and only three percent (3%) donate more than once yearly. Fortunately, 80 percent of blood
donors are repeat donors (James et al., 2012; Seifried et al., 2011; Erickson et al., 2008; Zou et
al., 2008; Pitocco & Sexton, 2005; Hess, 2004; USGAO, 2002).
Often, the public mistakenly views the blood supply as a depository of liquid RBC units,
indefinitely stocked and consistently available to withdraw any amount to meet any demand.
However, developing a blood supply is a complex, multi-factorial process that involves extensive
donor screening, various collection strategies, complicated blood component separation
processes, numerous strict testing procedures, massive distribution routes, and storage challenges
(Erickson et al., 2008; Zou et al., 2008). Whole blood cannot be stored or stockpiled into a
reserve. Within 24 hours after donation, the whole blood must be separated into its components
to include RBC’s, platelets, and plasma, with storage shelf-lives of five to forty-two days.
Therefore, blood collection centers depend heavily upon living donors who regularly donate
blood to build and maintain an adequate supply of blood products and consistently meet the
customer demands, striving to maintain an average three to five-day supply of red blood cells,
the most commonly used product (Erickson et al., 2008; Zou et al., 2008; McCarthy, 2007).
Despite the efforts of these blood donor agencies, 95 percent of the population fails to donate in
any given year and 60 percent of the population has never donated (Solomon, 2012).
Interestingly, however, major disasters have provoked a strong sense of altruism within
the people of communities to donate blood and results in a massive influx of donors and
collection of blood largely in excess of the actual needs of the disaster victims. Given the short
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shelf-life of RBC products, this type of a response is logistically taxing and wasteful. In these
situations, qualified phlebotomy personnel are in short supply at the blood donation centers and
there may be hasty recruitment of poorly trained temporary blood center staff. The lack of
properly trained staff and oversight leads to a higher risk of collection, processing, testing, and
storage errors. Because the supply often exceeds the demand, most of the donated blood
becomes outdated and is discarded. This can damage public relations as the donors become
disheartened that their “gift of life” was not used to save lives (Stanger, Yates, Wilding, &
Cotton, 2012; Kuruppu, 2010; Erickson et al., 2008).
The terrorist attack in America on September 11, 2001 serves as an example of this
scenario. During the immediate aftermath of the attacks in New York City, there was an
extraordinary influx of local blood donors, with major backups and long waiting lines. This
prompted the Federal Drug Administration (FDA) to allow partially trained technicians to
collect, process, and test the blood. Partially tested units of blood labeled “For Emergency Use
Only” expended valuable storage space and resources, comprising a substandard supply that was
eventually wasted. Overall, almost 600,000 extra units of blood were collected and
approximately 250,000 units were discarded with financial losses topping $5 million (Stanger et
al., 2012; Kuruppu, 2010; Erickson et al., 2008; Hess & Thomas, 2003). Increasing donor
motivation during times of normal operations and decreasing the emotional altruistic response
during times of a crisis are the keys in balancing the supply and demand sides of the transfusion
process.
However, blood is traditionally a scarce commodity and future challenges to ensure a
sufficient blood supply will likely present themselves in most communities for a number of
reasons. The percentage of Americans aged 65 years and older is expected to rise from 12.6

IMPLEMENTING THE ACP-215 AT A COMMUNITY BLOOD CENTER

11

percent in 2000 to 20 percent by 2030, an increase of more than 30 million people. By 2050, this
population is anticipated to double in size (Sayers & Centilli, 2012; Seifried et al., 2011; Zou et
al., 2008). This population will more likely receive rather than donate blood as their risk for
developing chronic diseases (cardiovascular disease, diabetes, malignancy) and need for complex
surgical procedures requiring blood transfusions increases (Sayers & Centilli, 2012; Seifried et
al., 2011; Zou et al., 2008). Therefore, the need to maintain a consistent national blood supply
will become more urgent.
More than 16 million blood donations occur annually, providing blood products to more
than 4 million recipients (Solomon, 2012; McCarthy, 2007). However, despite these donations,
episodes of periodic and predictable acute shortages have recurred, creating unmet demands for
blood products and affecting overall patient care (Solomon, 2012; Erickson et al., 2008;
McCarthy, 2007). Predictable shortages of all blood types occur during the summer months and
winter holidays, particularly because the donor numbers are down due to vacations and changes
in routines (DCBC Transfusion Services Senior Staff, 12 February 2013; Solomon, 2012;
Erickson et al., 2008; McCarthy, 2007). In addition to these routine and predictable periods of
shortages, a number of unpredictable factors now challenge blood collection services and create
potentially serious blood shortage problems. These factors are related to the characteristics of
the blood products themselves, the donors, and the environment.
First, the storage capacity and shelf-life of donated liquid blood is limited, and therefore,
predisposes itself to wastage. As demonstrated in the aftermath of the 9/11 attacks, if donations
remarkably increase over a short period of time, some of this donated blood may not get used
before its shelf-life expires within the five to forty-two day window and some will be wasted.
Blood wastage is costly in terms of money, resources, and potentially negative donor relations
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and, therefore, limits the amount of liquid blood inventory maintained by the blood collection
centers (Solomon, 2012; Erickson et al., 2008; McCarthy, 2007).
Second, the number of potential donors in the United States is decreasing for various
reasons. Donors are rejected due to increased strict screening criteria such as travel to certain
countries, positive exposure status to certain infections or diseases, and donor participation in
various risky personal behaviors. Also, the willingness of people under age 50 to donate blood is
significantly lower than those aged 50 and older. Despite their altruism, people aged 50 and
older are predicted to receive rather than donate blood due to increased incidence of chronic
diseases and more complex surgical procedures requiring blood transfusions. With fewer people
donating and more people receiving blood products, the potential for extended near-future
critical blood shortages exists (Solomon, 2012; Erickson et al., 2008; Zou et al., 2008).
Lastly, the unpredictable nature of the physical environment creates additional stresses on
blood product supply and demand. Natural and manmade disasters create injury victims in need
of blood and remove individuals from the donor population (Hess & Thomas, 2003).
Unpredictable weather patterns, emerging infectious disease threats, and potential terrorist
attacks face blood collection centers worldwide. For example, an influenza pandemic can have
major impacts on the supply of blood products by increasing donor deferrals, decreasing donor
attendance and blood center staff availability, thereby disrupting blood collection services and
compromising the overall safety of the donated blood due to blood collection and processing by
inexperienced, temporary staff (Kuruppu, 2010; Erickson et al., 2008). Based on the
unpredictable nature of these factors affecting the blood supply, blood collection centers must
have blood management contingency plans in place to monitor and manage inventory levels
during all times of normal operations, temporary shortages, and critical long-term shortages.
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DCBC Blood Shortage/Disaster Plan
The Impact Status Table (Figure 1) monitors and grades daily inventory levels based on a
description of the impact levels, their causes, and recommended actions.
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This plan is designed to operate at all times and communicate to the hospitals the center’s current
inventory status during shortages with recommended actions for effective mobilization of blood
products. The DCBC strives to maintain a three-day inventory supply of all blood products
(DCBC, 2000a; DCBC Inventory Senior Staff, 1 March 2013).
The DCBC Impact Status Table schematically differentiates inventory levels into Green,
Yellow, Red, and Recovery Alert situations. The Green (Go) Level indicates no inventory
shortage exists, therefore, blood center and hospital transfusion services are to follow normal
operating procedures for ordering, shipping, receiving, and returning blood products (DCBC,
2000c).
The Yellow (Caution) Level indicates a short-term, temporary, localized inventory of less
than or equal to two days of one or more blood products or blood groups. This may result from a
sudden large unexpected need for products by a local trauma center treating a mass casualty
situation (DCBC, 2000c). The blood products will be consumed immediately in the beginning,
causing a temporary shortage in the inventory. But, the inventory is anticipated to recover in
approximately two days because the donor population is not expected to be affected by the local
incident causing the mass casualty (DCBC Transfusion Services Senior Staff, 12 February 2013;
DCBC, 2000c).
The Red (Stop) Level indicates a critical, long-term inventory of less than or equal to one
day of all products and blood types. This is used when a severe threat to the inventory has been
identified and is imminent, such as during a severe winter blizzard, a tornado, or an outbreak of
the pandemic flu. In these cases, the blood center will be shut down with only essential
personnel remaining for extremely limited operations. The donors will not have access to the
center and the mobile units will be inoperable. In fact, the donors may likely be affected by the
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disaster themselves, either ill or stranded in their homes. The blood shortage will be long-term,
recovery of the inventory is anticipated to be prolonged, and supplies will need to be purchased
and distributed from outside resources. Blood shortage notifications are issued to the local
hospitals served by the DCBC when the impact level is Yellow or Red (Dayton CBC
Transfusion Services Senior Staff, 12 February 2013; DCBC, 2000c).
The Recovery (Restock) Level indicates the threat to the inventory level has been
removed and inventory levels are expected to gradually return to normal status. The DCBC will
continue to strictly manage the blood supply until the risk of destabilizing the recovery is
eliminated. Hospitals are notified of the Recovery Level once the overall threat is removed.
Daily notifications to the hospitals cease when the impact level returns to the Green level
(DCBC, 2000c). Figure 2 demonstrates a decision flow-chart used by the DCBC to assist
hospitals with implementing this plan (DCBC, 2000b).
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After the 9/11 attacks, the US blood center community established the American
Association of Blood Banks (AABB) Interorganizational Task Force on Domestic Disasters and
Acts of Terrorism. This task force is composed of ABC, the ARC, the Armed Services Blood
Program Office, and local community blood centers from around the nation. It seeks to improve
community blood center disaster preparedness efforts by sustaining sufficient inventory levels,
effectively managing donation rates, and developing efficient communication and transportation
routes for emergency blood inventory management (Kuruppu, 2010; AABB, 2008; Erickson et
al., 2008).
During any short-term acute increase in demand or a long-term critical supply shortage,
the affected blood collection center will assess the local need for blood products and
communicate this need to the AABB task force. The task force reviews the situation, convenes
with other blood collection centers in the region of the affected center, recalls needed blood
product supplies from unaffected centers, and coordinates the quickest form of transportation to
deliver the products to the affected blood collection center. The task force continues to interface
with the affected center and all unaffected centers in the region and manage the supply shortage
as described above, until the crisis has resolved (Kuruppu, 2010; AABB, 2008; Erickson et al.,
2008).
Although this system efficiently provides blood components to affected centers, it can
potentially leave unaffected regional centers secondarily undersupplied. Local disasters can
create a trickle-down effect, where a local supply shortage can deplete the supplies of an entire
region and its surrounding areas, and produce further shortages (DCBC Transfusion Services
Senior Staff, 12 February 2013; Erickson et al., 2008). Therefore, the focus has now shifted
toward maintaining an adequate inventory of blood products at all times through the
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development of a strategic reserve blood supply. This reserve would allow blood collection
centers to improve inventory management, maintain normal operations, and extend limited
supplies and resources during a short-term or long-term blood supply deficit, ultimately
improving their emergency preparedness efforts. The key component to this strategy is the
development of a reserve of cryo-preserved red blood cells (DCBC Transfusion Services Senior
Staff, 12 February 2013; Erickson et al., 2008; Ramsey, 2008; USGAO, 2002).
Blood Cryopreservation
Cryopreservation of blood product is defined as the process of freezing a blood product to
a very low temperature and storing it at that same temperature to protect the product’s normal
biological structure and function, allowing for long-term product storage (Scott, Lecak, & Acker,
2005). Damage during freezing and thawing must be minimized to maintain these desirable
qualities. Injuries to RBCs from freezing are reduced with the addition of a chemical cryoprotectant agent, glycerol, during the RBC freezing process. However, post-thaw washing of the
RBC’s to reduce the glycerol concentration to one percent is necessary to prevent posttransfusion intravascular hemolysis (Johnson & Swiatkowski, 2007; Valeri & Ragno, 2006; Scott
et al., 2005). In 1950, Dr. Audrey Smith of the National Institute for Medical Research
demonstrated that human RBC’s could be cryo-preserved with glycerol, thawed, rinsed free of
the glycerol, and transfused into recipients with normal survival of the recovered RBCs within
the recipient. Since then, more than a hundred facilities in the United States have frozen RBC
units, stored these units for several years, and, subsequently shipped these units all over the
world to various urban centers and remote rural locations for successful re-infusion into
recipients to meet the ever-increasing demand for transfusions. However, this freezing capability
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has been primarily restricted to the United States military and large hospitals due to time, labor,
and cost concerns (Chaudhari, 2009; Valeri & Ragno, 2006; Hess, 2004).
The development of strategic frozen RBC community reserves has several advantages.
Foremost, fresh frozen RBC units can be stored for 10 years (Ramsey, 2008) and, therefore
serves as a valuable resource during severe blood shortages. It would eliminate the need for
blood rationing and provide a continuous source of blood to support hospital needs without
relying on replenishment of blood products from outside regional blood collection centers
(Erickson et al., 2008; Bandarenko et al., 2007). Fresh frozen RBC units have an efficient
oxygen carrying capacity, are screened for infectious markers in advance of the urgent need for
transfusion, and is important during an infectious disease pandemic or bioterrorist attack, when
donor suitability and availability are low (Chaudhari, 2009). The strategic frozen RBC reserve
would support routine surgical, medical, and emergency procedures in the hospitals and,
therefore allow blood collection centers to meet blood product demands, sustain a balanced
budget, and maintain a favorable public image due to less wastage of donated blood (Erickson et
al., 2008).
However, despite these advantages, there are some disadvantages associated with the
freezing of RBCs using a traditional system. Previous cryopreservation systems are open
systems. An open system uses a non-sterile technique during the freezing and thawing processes
that lowers the threshold for potential bacterial contamination of the final RBC product, thereby
limiting the post-thaw shelf-life of this product to only 24 hours (DCBC Transfusion Technician,
7 March 2013; Haemonetics Sales Representative, 25 February 2013). In addition to this short
post-thaw shelf-life, the high costs and the labor-intensive, technically demanding nature of the
glycerolization and deglycerolization processes deterred many blood centers from developing a
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frozen RBC reserve. Cryopreservation had been available for more than 50 years, but the
freezing technology was stunted by slow, manual, and open systems (Chaudhari, 2009;
Bandarenko et al., 2007; Valeri & Ragno, 2006; Scott et al., 2005).
In 1998, a major scientific advance occurred when Haemonetics Corporation (Braintree,
Massachusetts) developed the Haemonetics Automated Cell Processor 215 (the ACP-215). This
cost-effective, efficient, closed system processor reduces the risks of bacterial contamination
during the glycerolization and deglycerolization processes. So, unlike the 24-hour expiration
from thaw to transfusion mandated by the open systems, RBCs processed with the ACP-215 can
be stored for up to 14 days post-thaw when resuspended in the appropriate nutrient solution,
resulting in an acceptable 24-hour post-transfusion RBC survival in the recipient and no posttransfusion adverse events (Chaudhari, 2009; Bandarenko et al., 2007; Johnson & Swiatkowski,
2007; Valeri & Ragno, 2006; Scott et al., 2005). The FDA granted Haemonetics Corporation
clearance in 2001 for the ACP-215 to be used in the transfusion services industry (Ramsey,
2008). Since then, this instrument has been widely used by the United States Department of
Defense and several large hospitals within the United States. Its use by the DCBC is now being
encouraged through a grant offered by the Greater Dayton Area Hospital Association Emergency
Preparedness Committee.
Methodology
The primary investigator performed a cost-benefit analysis of implementing the ACP-215
at the not-for-profit DCBC in Ohio to improve its emergency preparedness efforts. A literature
search and review was accomplished to gain an understanding of the operability, efficacy, safety,
and clinical uses of the ACP-215. The operational advantages and disadvantages of the ACP215 were studied and documented. The primary investigator conducted interviews with
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Haemonetics Corporation personnel, transfusion medicine personnel who use the device, and the
DCBC inventory, donor relations, and transfusion safety personnel to gain factual data on the
ACP-215 and personal experiences and opinions regarding the processor. All the data from the
interviews were collected anonymously with no personally identifiable information documented.
Then, data on all the costs related to the ACP-215, including the costs of purchase,
supplies, training, maintenance, and repairs, were collected. The Haemonetics sales staff
provided this data upon request by the primary investigator. The DCBC desired to purchase two
ACP-215 processors and submitted a proposal to the Greater Dayton Area Hospital Association
(GDAHA), requesting grant money to fund the purchase these two processors.
The DCBC anticipated processing 350 RBC units per year by predicting, at most, two
shortages annually (summer and winter holiday shortages) in which 150 frozen RBC units are
needed per crisis (DCBC Hospital and Laboratory Services Staff Interview, 12 February 2012).
Therefore, the annual cost of supplies was calculated to process 350 RBC units per year. The
purchase of one operator manual and one service manual was added to the costs of supplies.
Staff training would be conducted by the Haemonetics sales representative and is
included with the purchase of the processor. The DCBC currently has one trained medical
transfusion technician, who would train the other eight technicians (Haemonetics Sales
Representative, 28 February 2013; DCBC Transfusion Technician, 7 March 2013).
For a center having two processors, the “pay as you go” service contract was the most
cost-effective plan. The cost of this service contract includes one preventive maintenance
service per machine, a service engineer travel cost, and any necessary repairs or emergency
issues. In the US, the ACP-215 is currently 98% reliable and the need for emergency repairs is
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“rare”, therefore the cost of repairs was not included in this cost analysis (Haemonetics Sales
Representative, 28 February 2013).
The cost of purchasing two processors, maintaining supplies to process 350 units of
RBCs per year, training nine transfusion technicians, and administering one annual preventive
service per machine was summed to determine the total cost for ACP-215 implementation. The
cost of the two processors was then subtracted from this total as grant money would be used in
this acquisition. The result was the initial start-up cost to the DCBC to implement the ACP-215.
Then, the one-time purchase of the two ACP-215 manuals was subtracted from the initial startup cost as the two manuals were not considered recurring annual costs. The result was the
recurring annual cost to the DCBC to implement the ACP-215.
Then, the DCBC's annual import budget and expense reports from 2007 to 2012 were
collected. The DCBC’s Inventory Senior Staff provided this data upon request by the primary
investigator. An import is defined as the purchase of a blood product from an outside source
when the blood center’s inventory of that particular product is unable to meet the demand from
the community (DCBC Inventory Senior Staff, 1 March 2013). The annual import budget was
compared to the annual import expenses for each year from 2007 to 2012.
The estimated cost of annual import expenses expected with the addition of a strategic
frozen RBC reserve at the DCBC was calculated for 2007 to 2012. This estimated cost was
compared to the actual annual import expenses without the strategic frozen RBC reserve for
2007 to 2012. Then, the difference between the actual annual import expenses and the estimated
annual import expenses was calculated. The result was the cost-savings afforded to the DCBC if
they had implemented the ACP-215 to establish a strategic frozen RBC reserve.
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The primary investigator determined that implementation of the ACP-215 would benefit
the DCBC from an advantage-disadvantage and cost-savings perspective if the advantages
double the disadvantages and the comparison of annual import costs with and without ACP-215
implementation results in an annual cost-savings. This methodology was approved by the IRB
as exempt (Appendix A).
Results
Logisitics, Benefits and Limitations
The Haemonetics Corporation (Braintree, MA) developed the ACP-215 device in 1998.
This automated, functionally closed medical device performs the entire freeze-thaw-wash
process in 3 steps: glycerolization, deglycerolization, and resuspension in additive solution. Via
the ACP-215 instrument, one liquid RBC unit is sterilely attached to a disposable glycerolization
kit to add glycerol to the liquid RBC unit. The glycerolized RBC concentrate and its container
are wrapped up in a plastic bag, placed within a rigid cardboard box, and stored in a mechanical
freezer set at -80 degrees Celsius to freeze the glycerolized RBC unit. Glycerol is a cryoprotectant agent that minimizes ice crystal formation and, consequently prevents RBC membrane
damage during freezing (DCBC Transfusion Technician, 7 March 2013). The blood center then
stores these frozen glycerolized RBC units for a 10-year storage limit (Peyrard, Pham, Le
Pennec, & Rouger, 2009).
When a frozen RBC unit is needed, the rigid cardboard box containing the frozen
glycerolized RBC unit is removed from the storage freezer. The glycerolized RBC and its
container are removed from the cardboard box, unwrapped from the plastic bag, and placed into
a thawing bath maintained at 36 degrees Celsius for 40 minutes, to achieve a surface temperature
of 34 degrees Celsius, monitored by an infra-red scanner. The thawed glycerolized RBC
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concentrate is then sterilely attached to a disposable deglycerolization kit via the ACP-215
instrument to remove the previously added glycerol from the RBC concentrate (DCBC
Transfusion Technician, 7 March 2013).
After washing, the RBCs are resuspended in an additive solution (AS), referred to as AS3. The AS-3 solution contains glucose, adenine, and phosphate to provide nourishment for the
RBCs during storage. Deglycerolized RBCs processed in the Haemonetics ACP-215 can be
stored in the AS-3 for up to 14 days at four degrees Celsius and maintain less than one percent
hemolysis during storage (DCBC Transfusion Technician, 7 March 2013). Current regulations
require that thawed deglycerolized RBCs have a post-thaw recovery of at least 80% and a
hemolysis rate below one percent (Henkelman et al., 2010).
The ACP-215 provides numerous advantages in the development of a strategic frozen
RBC supply. It extends post-thaw liquid RBC unit storage from 24 hours to 14 days. The ACP215 is an automated, standardized, and closed system that performs the glycerolization and
deglycerolization processes in a sterile environment. Subsequently, this system minimizes the
risk of bacterial contamination of the RBC units and lengthens their post-thaw shelf-life to 14
days (Haemonetics Sales Representative, 25 February 2013; Henkelman, Lagerberg, Graaff,
Rakhorst, & Van Oeveren, 2010; Bandarenko et al., 2007; Grabmer et al., 2006)
The ACP-215 maintains acceptable RBC quality after processing and storage of the RBC
units in the AS-3 nutrient solution for up to 14 days. Studies demonstrate satisfactory viability
and function of the thawed deglycerolized RBC units processed with the ACP-215. Post-thawed
RBCs had normal morphology and normal oxygen transport functions with an acceptable freezethaw-wash recovery of approximately of greater than 80%, maintenance of aggregability and
deformity allowing for the easy passage of RBCs through the vascular system, and a mean
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hemolysis rate of less than one percent after storage in the AS-3 for 14 days (Haemonetics Sales
Representative, 25 February 2013; Henkelman et al., 2010; Chaudhari, 2009; Peyrard et al.,
2009; Bandarenko et al., 2007).
The ACP-215 cell processor has been continuously licensed by the FDA since 2001. The
washing of thawed RBCs eliminates most cell debris, white blood cells, platelets, residual
plasma, and other potential allergens, thereby reducing the occurrence of potential posttransfusion reactions. Furthermore, the extended 14-day post-thaw storage period allows more
time for pre-transfusion safety testing (Haemonetics Sales Representative, 25 February 2013;
Peyrard et al., 2009; Erickson et al., 2008; Scott et al., 2005).
This device is 50% more efficient compared to other non-automated, manually operated
processors. The total freeze-thaw-wash process using the ACP-215 technology requires 2 hours.
It glycerolizes 3 liquid RBC units in 1 hour and deglycerolizes 1 thawed RBC unit in 1 hour.
However, deglycerolization requires only 15 minutes of the operator’s time, allowing the
operator to accomplish other tasks during the remaining 45 minutes. Therefore, the total time to
process 3 RBC units for freezing and 1 RBC unit for transfusion, using the ACP-215, is 75
minutes per operator, down 50% from the 150 minutes total time using the typical manually
operated machines to process the same amount of product (Haemonetics Sales Representative,
25 February 2013).
The ACP-215 cell processor permits a blood product supplier to have a well-managed
inventory of blood products. With the reduction in the donor population due to various reasons
previously described and the extended 14-day post-thaw shelf-life of the RBC products, the
strategic frozen RBC supply can be used to supplement the liquid RBC reserve, maximize
inventory flexibility, and reduce expensive wastage. Suppliers will ultimately have an increased
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control of the supply to meet the demand of RBC products under most circumstances
(Haemonetics Sales Representative, 25 February 2013; Erickson et al., 2008; Valeri & Ragno,
2006). The ACP-215 offers many benefits in the development of the strategic blood supply.
However, there are disadvantages to consider.
Staffing by trained technicians during an emergency is essential for successful
implementation of the ACP-215. Unfortunately, many emergency or disaster situations that
affect the blood supply can also affect staffing levels, such as inclement weather, transportation
problems, or an infectious disease pandemic. Trained staffing must be adequate to deploy the
strategic frozen blood supply, in addition to maintaining normal operations (Erickson et al.,
2008). This will increase the workload on certain departments within the blood center,
particularly the donor relations, blood components, and inventory departments. Donor relations
will need to recruit more donors to replenish both the strategic frozen and liquid RBC supplies.
The components department will need to work longer shifts to thaw the needed RBC units from
the frozen reserve and then freeze more RBC units to replenish those used from this reserve.
And, the increased inventory oversight and periodic refreshing of frozen units to prevent wastage
of outdated products (at 10 years) increases the inventory department’s responsibilities (DCBC
Donor Relations Senior Staff, 12 February 2013; DCBC Inventory Senior Staff, 1 March 2013).
Each ACP-215 operator must have initial and annual training on how to freeze liquid
RBC’s for storage and select, thaw, and process frozen RBC units for transfusion. Supervisors
must continuously monitor and periodically evaluate the operators for competency in these skills.
Insufficient training in these areas weakens the effectiveness of the strategic frozen RBC reserve
(Haemonetics Sales Representative, 25 February 2013; Erickson et al., 2008).
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Adequate storage of equipment, supplies, and products is a crucial component of the
frozen RBC reserve. An isolated, easily accessible countertop space is required on which to
place the ACP-215 device. Several large shelves and cupboards, nearby the device, are needed
for the storage of multiple supplies. The maintenance of a large number of frozen RBC units
requires an operable and spacious -65 degrees Celsius or colder freezer unit. And, optimal
deployment of the strategic frozen RBC reserve necessitates reliable electricity with appropriate
back-up generator support if needed (DCBC Transfusion Technician, 7 March 2013; Erickson et
al., 2008).
Development of a strategic, frozen community blood supply and its appropriate
implementation requires close communication between the blood center senior staff and its
employees, state and federal agencies, local law enforcement, public utilities, hospital clinicians,
and donors. During critical blood product shortages, the senior staff must decide when to begin
thawing procedures and assign employees to that task. It must assess the ongoing situation and
communicate it to the state and federal emergency offices that provide additional assistance,
local law enforcement agencies that assist with transport of blood supplies, public utilities that
resume various essential services if they are non-functional, hospital clinicians who rely upon the
blood supply to provide services to their patients, and the donors who provide needed blood
donations. Many unforeseeable events to include loss of electricity, loss of communication
channels, simultaneous mass casualties requiring immediate access to liquid blood, or
destruction of the blood collection center itself can complicate this communication issue even
further (DCBC Transfusion Services Senior Staff, 12 February 2013; Erickson et al., 2008). In
addition to these operational advantages and disadvantages, the DCBC must also consider the
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total costs involved with utilization the ACP-215 in the development of the strategic frozen RBC
reserve.
Cost Comparison
Table 1 demonstrates the total annual costs incurred by the DCBC to implement the
ACP-215 cell processor in development of a strategic frozen RBC reserve.

The first item on this table shows the total cost of two ACP-215 devices. This purchase would
be covered with the grant money given to the DCBC by the GDAHA, and therefore poses no
direct cost to the center itself (DCBC Transfusion Services Senior Staff, 12 February 2013;
DCBC Hospital and Laboratory Services Senior Staff, 13 March 2013).
The total supply cost was calculated based on an estimation of processing 350 RBC units
per year. The supplies include the glycerolization kit, the deglycerolization kit, the AS3
resuspension nutrient solution, one ACP-215 Operator manual, and one ACP-215 Service
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manual. The two manuals represent a one-time purchase only and were not considered annual
recurring costs (Haemonetics Sales Representative, 28 February 2013).
Staff training would be free with the purchase of the ACP-215. One lead technician,
trained by the Haemonetics sales representative, would continue to train the other eight DCBC
transfusion technicians. Thus, training poses no cost to the DCBC (DCBC Hospital and
Laboratory Services Senior Staff, 13 March 2013, Haemonetics Sales Representative, 28
February 2013).
The ACP-215 requires one preventive maintenance visit per year. Routine maintenance
would be done by the DCBC staff on a daily or monthly basis at no additional cost to the center.
The one annual preventive maintenance visit would be the only service requiring a Haemonetics
service engineer to travel to the center. The final cost analysis concluded that the initial start-up
cost to the DCBC for ACP-215 implementation was calculated to be $38,586.90 and the
subsequent annual recurring cost would be $37,386.90.
Figure 3 demonstrates the DCBC’s annual import budget and expenditures from 2007
through 2012. The DCBC’s import budget is designated for the purchase of imports only. It has
a separate budget designated for the purchase of supplies and another for the purchase and
maintenance of equipment. The import expenditures involve the purchase of RBC, platelet, and
plasma products only. These expenditures exceeded the import budget every year from 2007 to
2012 (DCBC Inventory Senior Staff, 1 March 2013).
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Figure 4 compares the annual costs between import expenditures with and without
implementation of the ACP-215 from 2007 through 2012. The import expenditures without the
ACP-215 include RBC, platelet, and plasma product purchases. The import expenditures with
the ACP-215 would include platelet and plasma product purchases only. It would exclude the
purchase of RBC product imports because, theoretically, the DBCB would have used it frozen
RBC reserve to cover the shortage in its liquid RBC inventory. The cost of imports without the
ACP-215 each year between 2007 and 2012 either exceeded or equaled the estimated cost of
imports expected with the addition of the ACP-215 implementation. In 2010 and 2011, the
DCBC purchased only platelet and plasma product imports. No RBC product imports were
purchased during those 2 years (DCBC Inventory Senior Staff, 1 March 2013).
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Figure 5 demonstrates the final cost-savings to the DCBC if it had implemented the ACP215 from 2007 through 2012.

The cost-savings is either a significantly positive number or zero from 2007 to 2012, with an
average cost-savings of $249,000 over those 5 years. The cost-savings would be zero in 2010
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and 2011 because the blood center purchased only platelet and plasma product imports. No RBC
product imports were purchased during those 2 years (DCBC Inventory Senior Staff, 1 March
2013).
Discussion
The ACP-215 device would be a valuable resource for the DCBC in its efforts to develop
a strategic frozen RBC reserve to be used during a crisis when critical long-term blood product
shortages are in effect. As Figure 3 summarizes, the ACP-215 is a safe, efficient, and effective
device that allows for long-term storage of frozen RBC units of up to 10-years, extends the postthaw shelf-life up to 14 days, and meets required post-storage RBC standards for quality and
function (Henkelman et al., 2010; Peyrard et al., 2009; Bandarenko et al., 2007). In terms of
emergency preparedness efforts, these advantages offered by the ACP-215 are “huge for the
Dayton Community Blood Center” (DCBC Transfusion Services Senior Staff, 12 February
2013).
The ACP-215 does present unique challenges or disadvantages, most notably with
staffing, training, storage capacity, and communications. The DCBC has developed several
written disaster plans and a freezing schedule to address these issues. During a trauma case,
types O positive and O negative blood get hit the hardest because they are the universal donors
and the DCBC’s scarcest products. Therefore, the CBC plans to build the frozen reserve with O
positive and O negative RBC units first. After this reserve is established, the CBC could freeze
some type A and B units, but the type O products are the most important to have in the reserve
stockpile. The DCBC would build up its strategic supply during times of heavy donations,
freezing 10-20 units a week, depending upon availability of the blood, until the reserve was
complete. The selected freezer would hold up to 350 RBC units (DCBC Donor Relations Senior
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Staff, 12 February 2013; DCBC Transfusion Services Senior Staff, 12 February 2013; DCBC
Hospital and Laboratory Services Senior Staff, 13 March 2013).
Ideally, a strategic supply is reserved for use only during an emergency, when the donors
are also affected by the particular crisis. But, the reserve units could be used during the lean
months if necessary (DCBC Transfusion Services Senior Staff, 12 February 2013). For example,
in December 2012, there were five to six days of almost no blood collections due to a blizzard
that hit the Dayton area, as well as an increase in flu incidence among the elderly. The DCBC
was unable to sustain its supply to meet the demands from the community and, therefore had to
rely on imports. This cost the center $28,250 in RBC and platelet product imports. The center
could have saved at least $23,500 if a frozen RBC reserve was stockpiled using the ACP-215
device (DCBC Donor Relations Senior Staff, 12 February 2013; DCBC Inventory Senior Staff, 1
March 2013).
Figure 5 demonstrates that the DCBC would gain significant savings with
implementation of the ACP-215 to establish a strategic frozen RBC reserve, theoretically
recovering an average of $249,000 over 2007 to 2012. A strategic frozen blood supply results in
better inventory management during longer periods of critical shortages by freeing up more
resources. For example, if there is a shortage of platelets, the center can use the frozen RBC
reserve to supplement the liquid RBC reserve and redirect its focus on donor platelet collections,
as platelets have only a 5-day post-collection shelf-life and cannot be frozen (DCBC Transfusion
Services Senior Staff, 12 February 2013). In 2010 and 2011, the CBC imported only platelet and
plasma products. No RBC product imports were purchased, resulting in no theoretical costsavings per Figure 5. However, if a frozen RBC stockpile was in place, the center could have
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used this reserve to supplement the liquid RBC inventory and could have redirected its resources
to increasing platelet and plasma collections, avoiding import purchases.
This case study presents some limitations. It is difficult to estimate when a crisis or
critical shortage will occur and how many frozen RBC units will need to be thawed in response
to a particular crisis. This cost-analysis used the figure of processing 350 RBC units per year by
predicting, at most, 2 shortages per year (summer and winter holiday shortages) in which 150
frozen RBC units are needed per crisis (this is the amount that was needed during the blizzard of
December 2012). And, only one RBC unit can be thawed in one hour using the ACP-215. With
two ACP-215 devices and one eight hour shift per technician, approximately 16 units per
technician can be thawed in one hour. Sixteen RBC units per hour may not be sufficient to deal
with a particular emergency or critical RBC shortage. Once the DCBC has developed its frozen
reserve and begins to utilize it in times of shortages, more specific figures can be used to reflect
more accurate calculations.
It is also difficult to estimate the cost of emergency calls to repair the ACP-215. The
repair could be a minor problem or a major problem. The average cost per emergency service
call from the last 12 months in North America is $657 per call. This is the cost of parts only and
does not include the engineer travel cost if an engineer should be needed by the center.
However, the ACP-215 does not fail often. Over the last 12 months globally, the failure rate has
been one failure per 700 procedures done. With a 98% reliable rating, the need for repairs to the
instrument is extremely rare (Haemonetics Sales Representative, 28 February 2013). Further
research into all of these areas is needed.
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Conclusion
Blood is a costly and scarce resource, not to be used irresponsibly or wasted. As the
number of blood donations decline and transfusion needs rise, critical shortages of blood
products will continue, especially during the summer and winter holidays and potential
emergencies. Effective strategies are needed to maintain a blood product supply that will meet
the demands under any circumstances. The establishment of a strategic frozen RBC reserve is
one strategy that effectively manages blood usage and minimizes waste (McCarthy, 2007;
Shander et al, 2007). Overall, the benefits of the Dayton CBC implementing the ACP-215
device to establish its strategic frozen RBC reserve and improve its emergency preparedness
efforts outweigh the disadvantages and costs, particularly where seasonal shortages, weather
conditions, and a decreasing donor population chronically threaten the community’s blood
supply.
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Appendix B – List of Tier 1 Core Public Health Competencies Met
Domain #1: Analytic/Assessment
Identify the health status of populations and their related determinants of health and illness (e.g., factors
contributing to health promotion and disease prevention, the quality, availability and use of health services)
Describe the characteristics of a population-based health problem (e.g., equity, social determinants,
environment)
Use variables that measure public health conditions
Use methods and instruments for collecting valid and reliable quantitative and qualitative data
Identify sources of public health data and information
Recognize the integrity and comparability of data
Identify gaps in data sources
Adhere to ethical principles in the collection, maintenance, use, and dissemination of data and information
Describe the public health applications of quantitative and qualitative data
Collect quantitative and qualitative community data (e.g., risks and benefits to the community, health and
resource needs)
Use information technology to collect, store, and retrieve data
Describe how data are used to address scientific, political, ethical, and social public health issues
Domain #2: Policy Development and Program Planning
Gather information relevant to specific public health policy issues
Describe how policy options can influence public health programs
Explain the expected outcomes of policy options (e.g., health, fiscal, administrative, legal, ethical, social,
political)
Gather information that will inform policy decisions (e.g., health, fiscal, administrative, legal, ethical, social,
political)
Participate in program planning processes
Incorporate policies and procedures into program plans and structures
Apply strategies for continuous quality improvement
Domain #3: Communication
Communicate in writing and orally, in person, and through electronic means, with linguistic and cultural
proficiency
Solicit community-based input from individuals and organizations
Participate in the development of demographic, statistical, programmatic and scientific presentations
Apply communication and group dynamic strategies (e.g., principled negotiation, conflict resolution, active
listening, risk communication) in interactions with individuals and groups
Domain #4: Cultural Competency
Incorporate strategies for interacting with persons from diverse backgrounds (e.g., cultural, socioeconomic,
educational, racial, gender, age, ethnic, sexual orientation, professional, religious affiliation, mental and
physical capabilities)
Recognize the role of cultural, social, and behavioral factors in the accessibility, availability, acceptability
and delivery of public health services
Respond to diverse needs that are the result of cultural differences
Domain #5: Community Dimensions of Practice
Recognize community linkages and relationships among multiple factors (or determinants) affecting health
(e.g., The Socio-Ecological Model)
Demonstrate the capacity to work in community-based participatory research efforts
Identify stakeholders
Collaborate with community partners to promote the health of the population
Maintain partnerships with key stakeholders
Use group processes to advance community involvement
Describe the role of governmental and non-governmental organizations in the delivery of community health
services
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Domain #5: Community Dimensions of Practice (Cont’d)
Identify community assets and resources
Gather input from the community to inform the development of public health policy and programs
Inform the public about policies, programs, and resources
Domain #6:Public Health Sciences
Describe the scientific foundation of the field of public health
Identify prominent events in the history of the public health profession
Relate public health science skills to the Core Public Health Functions and Ten Essential Services of Public
Health
Identify the basic public health sciences (including, but not limited to biostatistics, epidemiology,
environmental health sciences, health services administration, and social and behavioral health sciences)
Describe the scientific evidence related to a public health issue, concern, or, intervention
Retrieve scientific evidence from a variety of text and electronic sources
Discuss the limitations of research findings (e.g., limitations of data sources, importance of observations and
interrelationships)
Describe the laws, regulations, policies and procedures for the ethical conduct of research (e.g., patient
confidentiality, human subject processes)
Partner with other public health professionals in building the scientific base of public health
Domain #7: Financial Planning and Management
Describe the local, state, and federal public health and health care systems
Describe the organizational structures, functions, and authorities of local, state, and federal public health
agencies
Adhere to the organization’s policies and procedures
Participate in the development of a programmatic budget
Operate programs within current and forecasted budget constraints
Identify strategies for determining budget priorities based on federal, state, and local financial contributions
Report program performance
Translate evaluation report information into program performance improvement action steps
Contribute to the preparation of proposals for funding from external sources
Apply basic human relations skills to internal collaborations, motivation of colleagues, and resolution of
conflicts
Demonstrate public health informatics skills to improve program and business operations (e.g., performance
management and improvement)
Participate in the development of contracts and other agreements for the provision of services
Describe how cost-effectiveness, cost-benefit, and cost-utility analyses affect programmatic prioritization and
decision making
Domain #8: Leadership and Systems Thinking
Incorporate ethical standards of practice as the basis of all interactions with organizations, communities, and
individuals
Describe how public health operates within a larger system
Participate with stakeholders in identifying key public health values and a shared public health vision as
guiding principles for community action
Identify internal and external problems that may affect the delivery of Essential Public Health Services
Use individual, team and organizational learning opportunities for personal and professional development
Participate in mentoring and peer review or coaching opportunities
Participate in the measuring, reporting and continuous improvement of organizational performance
Describe the impact of changes in the public health system, and larger social, political, economic
environment on organizational practices
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